Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission

AIDS Research and Human Retroviruses

Volumn 17, Issue 18, 2001, Pages 1725-1735

  Matala, Erik ^a   Hahn, Tobias ^a   Yedavalli, Venkat R K ^a   Ahmad, Nafees ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5;

ARTICLE; CELL GROWTH; CHIMERA; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA TRANSFECTION; ENVELOPE GENE; GENE SEQUENCE; GENOTYPE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOLECULAR CLONING; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SYNCYTIUM; T LYMPHOCYTE; VIRUS CHARACTERIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEQUENCE HOMOLOGY, AMINO ACID; VIRUS REPLICATION;

EID: 0035703329     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220152741423     Document Type: Article

References (55)

1. Maternal-fetal transmission of human immunodeficiency virus
2. Molecular mechanisms of human immunodeficiency virus type 1 mother-infant transmission
3. Mothers of infants with acquired immunodeficiency syndrome: Evidence for both symptomatic and asymptomatic carriers
4. Risk for perinatal HIV transmission according to maternal immunologic, virologic, and placental factors
5. Epidemiology, clinical features, and prognostic factors of pediatric HIV, infection
6. Maternal factors associated with perinatal HIV-1 transmission: The French Cohort Study: 7 Years of follow-up observation
7. Epidemiology of HIV infection and AIDS: Incubation and infectious periods, survival, and vertical transmission
8. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant
9. Mother to child transmission of HIV-1
10. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
11. Selective vertical transmission of HIV-1 antiretroviral resistance mutations
12. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission
13. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with RNA DNA sequences of virus population of their mothers
14. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child
15. Selective transmission of human immunodeficiency virus type-1 variants from mother to infants
16. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection
17. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
18. Macrophage and T cell line tropism of HIV-1 are determined by specific regions of the envelope gp120 gene
19. In vitro mutagenesis identifies a region with the envelope gene of human immunodeficiency virus that is critical for infectivity
20. Functional interactions of constant and variable domains of HIV that are critical for infectivity
21. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120
22. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein
23. Type-specific neutralization of the human immunodeficiency virus with antibodies to envencoded synthetic peptides
24. HTLV II/LAV neutralizing antibodies to an E. coli produced fragment of the virus envelope
25. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein
26. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo
27. Identification of the envelope V3 loop as the primary determinant of cell tropism
28. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread
29. Amino acid substitutions in the HIV-1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope
30. Evidence that the structural conformation of the envelope gp120 affects HIV-1 infectivity, host range, and syncytium-forming ability
31. Functional role of the V1/V2 region of HIV-1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
32. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
33. HIV-1 entry co-factor: Functional cDNA cloning of a seven transmembrane, G protein-coupled receptor
34. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
35. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes
36. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1
37. Effect of a single amino acid substitution in the V3 domain of the human immunodeficiency virus type 1: Generation of revertant viruses to overcome defects in infectivity in specific cell types
38. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication
39. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation
40. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor
41. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity
42. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission
43. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: Role of the V3 loop and C4 envelope determinants
44. Features of HIV-1 that could influence maternal-child transmission
45. Identification of a major co-receptor for primary isolates of HIV-1
46. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
47. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
48. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1
49. CD4, CXCR-4, and CCR-5 Dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
50. CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo
51. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism
52. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: In vivo evolotion of vpr quasispecies in blood and plasma
53. Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission
54. Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission
55. Proposed definitions forin utero versus intrapartum transmission of HIV-1